Epitomee Medical

medical devices

About

Epitomee Medical is a public company focused on developing and commercializing innovative ingestible therapeutic devices for targeted therapies in the gastrointestinal (GI) tract. Their core product platform features swallowable capsules designed to deliver therapies precisely in specific areas of the stomach, duodenum, and small intestine. These capsules enable mechanosensory stimulation, targeted drug delivery, and absorption management, dissolving naturally after use. The company's technology is adaptable for various applications, including weight management, biologics delivery, and chronic disease management. Epitomee Medical collaborates with multinational industry leaders to advance new applications that align with strategic needs, aiming to enhance patient outcomes. The leadership team includes Dr. Dan Hashimshony, who has a strong background in biomedical engineering, and Yael, who specializes in clinical and regulatory affairs.

Technologies

Outlook Microsoft Office 365 Linkedin Marketing Solutions Mobile Friendly WordPress.org Google Tag Manager reCAPTCHA Typekit AI

Keywords

medical devices medical device drug delivery oral delivery therapeutic devices ingestible devices ingestible therapeutic device weight management epitomee capsule gi tract biologics delivery ingestible medical device therapeutic medical devices medical equipment manufacturing hydro-gel scaffolds transient activity ingestible therapeutic devices ph-responsive hydrogel clinical validation targeted drug absorption controlled disintegration regulatory approval hydrogel scaffolds pharmaceuticals partner collaborations self-ingested device patient adherence weight loss capsule ph-triggered activation controlled release

Location

Tarshish Industrial Park Street, Caesarea, Haifa District, Israel

Related Companies

Companies in the same industry